Stay updated with breaking news from Astrazeneca Brilinta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As per Future Market Insights’ latest industry analysis, the valuation for the global clot busting drugs market is estimated to be around US$ 28.8 Bn in 2022 and is projected to exhibit a CAGR growth of close to 7.3% over the forecast period, with an estimated valuation of US$ 58.4 Bn in 2032.The global market for c...
/PRNewswire/ -- The stroke therapeutics market is estimated to grow by USD 1.54 billion from 2020 to 2025, and the market's growth is anticipated to accelerate...
/PRNewswire/ -- The stroke therapeutics market is estimated to grow by USD 1.54 billion from 2020 to 2025, and the market's growth is anticipated to accelerate...
.jpg)
Drug patent expiry in 2021: Opportunities and challenges in the Korean market Min Son of Hanol IP & Law looks ahead at the key deadlines in the South Korean drug patent market for 2021 Sponsored by January 12 2021 With each new year, pharmaceutical companies are faced with the loss of exclusivity that accompanies the expiration of their patents, and by the same token, drug manufacturers are also afforded new opportunities and challenges due to the entry of generic competition. In South Korea, as many as 62 patents for 158 pharmaceuti...